Stephen Panton

Pawel Szaja is a top attorney recognized by Best Lawyers in the practice area(s) of Capital Markets Law. Pawel, who practices law in London, United Kingdom, has been recognized since 2024. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Pawel is held by other top lawyers in the same geographic and legal practice area.

Stephen Pollard is a seasoned litigator with more than 30 years of experience in the full spectrum of business crime and securities enforcement work. During his career, Mr. Pollard has been involved in most of the significant business crime investigations and prosecutions brought by the UK authorities. Mr. Pollard has particular experience in representing senior individuals from public and private companies, including those from the financial services sector. In addition, Mr. Pollard is regul...

Wim De Vlieger is a partner in the London office of Gibson, Dunn & Crutcher. Mr. De Vlieger is Co-Head of Private Equity in Europe and a member of the Mergers and Acquisitions and Capital Markets practice groups. Mr. De Vlieger advises private equity investors and their portfolio companies on a wide range of corporate transactions, including growth equity and control investments and co-investments, structured transactions, buy-out transactions, mergers and acquisitions, and exits. He also...

Morag Peberdy is a top attorney recognized by Best Lawyers in the practice area(s) of Life Sciences Law. Morag, who practices law in London, United Kingdom, has been recognized since 2017. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Morag is held by other top lawyers in the same geographic and legal practice area.

?Mitri J. Najjar is a partner in the London office. He is admitted in both Washington D.C. and New York. He has 30 years of experience representing a wide variety of clients in numerous international transactions. Mr Najjar has resided and practiced law in Riyadh, New York City, Washington D.C., Dubai and London. He works extensively in the international commercial and banking areas, as well as on domestic securities matters and acquisitions. Mr. Najjar is ranked as a ‘foreign expert&rs...

When multinational corporations consider major transactions, tax implications often make or break the deal. Charlotte Sallabank advises on those implications, advising clients on the direct and indirect tax consequences of their largest business decisions. Her creativity, persuasive power and close attention to her clients' business aspirations consistently result in solutions that make them a reality.A complete perspective on tax-planning issuesWith more than 30 years of experience advising ...

James Fisher is a partner in the Finance Group in Alston & Bird’s London office, focusing on debt capital markets, structured finance, securitisation, and derivatives transactions, with a particular specialty in advising corporate trust, agency, and issuer clients across a broad spectrum of cross-border and domestic financings.

Hamid Yunis advises clients on complex areas of transactional law (M&A, Investments, Private Equity, Major Projects and Corporate Finance) predominantly within the health industry and on infrastructure transactions. He has substantial global experience in innovative structures for complex joint ventures, public-private partnerships and funding arrangements. Hamid’s global client base includes health care providers, medical products manufacturers and organizations establishing &ldquo...

Mr. Anderson is highly experienced in private capital arrangements, with a particular focus on the establishment and ongoing operations of asset management structures; portfolio investments in liquid markets, infrastructure, real estate and technology; and compensation for fund principals.

Tim is a partner in Goodwin’s Technology and Life Sciences groups, based in the Cambridge and London offices.Mr. Worden regularly advises life sciences companies on licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad spectrum of regulatory matters. His expertise also includes advising on the IP and regulatory aspects of M&A transactions, IPOs and venture capital investments. Outside of the life sciences sector, Mr. Wor...